|1.||Ono, Koji: 9 articles (03/2006 - 12/2002)|
|2.||Kinashi, Yuko: 8 articles (03/2006 - 12/2002)|
|3.||Suzuki, Minoru: 8 articles (03/2006 - 01/2003)|
|4.||Nagata, Kenji: 8 articles (03/2006 - 01/2003)|
|5.||Masunaga, Shin-ichiro: 6 articles (08/2013 - 12/2002)|
|6.||Multhoff, Gabriele: 5 articles (01/2015 - 11/2003)|
|7.||Uto, Yoshihiro: 5 articles (03/2006 - 01/2003)|
|8.||Nagasawa, Hideko: 5 articles (03/2006 - 01/2003)|
|9.||Hori, Hitoshi: 5 articles (03/2006 - 01/2003)|
|10.||Sakurai, Yoshinori: 5 articles (02/2006 - 12/2002)|
02/01/2014 - "In all three in vivo injection paradigms, NSC-coupled NPs exhibited significantly improved tumor-selective distribution and retention over free-NP suspensions. "
06/01/1991 - "The automation of deparaffinization can thus provide a significant reduction in the labor need to produce single-cell suspensions for FCM; it can be especially helpful when handling large numbers of tumors. "
03/01/1980 - "These studies clearly establish that tumor cells may be eliminated from normal marrow suspensions without completely destroying the pluripotent stem cells."
09/01/2015 - "Evaluation of a human ovarian follicle isolation technique to obtain disease-free follicle suspensions before safely grafting to cancer patients."
08/28/2008 - "Suspensions of various known quantities of the HT-29 tumor cell line and patient hepatocytes were treated or not with Ep-CAM-antibody-coated immunomagnetic beads in order to investigate the efficacy of tumor-purging by immunomagnetic depletion, using a semi-quantitative RT-PCR method developed to detect tumor cells. "
08/01/1991 - "To elucidate the mode of infection of FDC with HIV-1 in vitro we developed an improved method for the preparation of single-cell suspensions of viable FDC with high purity (greater than 90% FDC). "
02/28/1930 - "1. Injection of suspensions of heat-killed pneumococci into the skin of rabbits is followed by an active immunity which is effective against intravenous infection by homologous and heterologous types of Pneumococcus. "
04/30/2007 - "Improved outcome of Trypanosoma cruzi infection in rats following treatment in early life with suspensions of heat-killed environmental Actinomycetales."
12/01/2011 - "The study of the target cells for the early infection in cell suspensions of blood and spleen showed that both non-adherent cell populations (enriched in lymphoid cells) and adherent cells (enriched in monocytes/macrophages) supported MD virus infection. "
06/01/2009 - "In our study, TNG was used for its ability to increase NO and to modify CL infection in mice, in order to evaluate NO effects on lesion size and formation, parasite proliferation inside macrophages, amastigote visceralization in target organs, and NO induction in plasma and organ suspensions. "
01/01/1991 - "The hemolysis of 0.5% suspensions of canine erythrocytes was used as a measure of the efficacy of this rotating exposure system. "
07/01/2014 - "The optimal hemolysis conditions were determined by diluting the bone marrow suspensions with distilled water in various dilution ratios. "
01/01/2014 - "Similarly, when erythrocytes suspensions were treated with either different concentrations of H2O2 (0.05-0.25 mM) along with BPA (50 μg/mL) or 0.05 mM H2O2 along with different concentrations of BPA (50-250 μg/mL), dose-dependent significant increase in hemolysis occurred. "
01/01/2014 - "When erythrocyte suspensions were treated with different concentrations of BPA/H2O2, a dose-dependent increase in hemolysis occurred. "
01/01/2014 - "Structural changes in the POPC multilamellar vesicles were assessed by small angle X-ray scattering, and the shape transformation of red blood cells after incubation in tested suspensions of nanoparticles was observed using scanning electron microscopy and sedimentation, agglutination, and hemolysis assays. "
|4.||Wounds and Injuries (Trauma)
10/28/2011 - "Given the increased interest in the isolation, characterization and functional measurements of wound-derived cell populations, herein we describe a method for preparing wound cell suspensions with an improved yield that enables both phenotypic and functional assessments."
05/01/2005 - "In order to evaluate the efficacy of local injection of activated macrophage suspensions into open infected sternal wound space, a retrospective case-control study was conducted. "
11/01/1994 - "In order to overcome these limitations, we have adopted a microtransplantation approach which allows precise and reproducible implantation of ventral mesencephalon cell suspensions at single or multiple sites with minimal trauma and improved survival and integration of the grafted neurons [Nikkhah et al. (1994) Brain Res. 633, 133-143]. "
11/01/2009 - "While previous studies have shown fibroblasts suspension to have little effect in the treatment of full thickness wounds in nondiabetic wounds, this study shows a clear beneficial effect in the use of fibroblast or keratinocyte suspensions for the cutaneous healing of diabetic wounds in pigs."
05/01/2009 - "This study demonstrated that suspensions of noncultured keratinocytes and melanocytes do not decrease the time to epithelialization of superficial partial thickness wounds compared with controls. "
12/01/1993 - "Clarithromycin and cefaclor suspensions were similarly effective for the treatment of acute otitis media. "
12/01/1993 - "The safety and efficacy of clarithromycin and amoxicillin suspensions were compared in the treatment of acute otitis media in children 1 to 12 years of age inclusive. "
11/01/1995 - "Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children."
01/01/1989 - "A total of 97 children with acute otitis media were entered into a single-blind, parallel-group study to compare the efficacy and tolerance of suspensions of bacampicillin, given twice daily, with amoxycillin, given three times daily. "
12/01/1993 - "Clarithromycin and cefaclor suspensions in the treatment of acute otitis media in children."
|1.||DNA (Deoxyribonucleic Acid)
|5.||Acetic Acid (Vinegar)
|1.||Drug Therapy (Chemotherapy)
|2.||Transplantation (Transplant Recipients)
|4.||Nebulizers and Vaporizers (Inhaler)